The weekly litigation news digest is live. Subscribe now

IP Verse

Highlight Therapeutics competitive analysis

Latest patents of Highlight Therapeutics opposed by its competitors

Explore Highlight Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 25, 2025
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Highlight Therapeutics

EP3319587
Aug 21, 2019Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine1

Latest PTAB cases involving Highlight Therapeutics

Discover the latest PTAB cases involving Highlight Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Highlight Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HIGHLIGHT THERAPEUTICS - 1 - -
TARGIMMUNE THERAPEUTICS1 - - -